Pavel Sokolovsky

All posts

tech, startups, internet · Sep 2023

Why QED is doubling down on Kin.

A laudatory memo from a recent investor in the Chicago-based insurance startup Kin (disclosure: I’m lucky to be a small investor as well). “The difference between these financial metrics is so stark that we believe Kin will be the defining company of insurtech 2.0. Whereas Lemonade, Hippo, and Root prioritized growth over control, likely believing that risk would normalize at scale, Kin’s model is based on a real understanding of…

better doing · Sep 2023

The secretary problem.

If you had a pool of 100 applicants for a secretary position, but had to hire or reject each applicant promptly after their interview, how many should you interview before making a hire? ~ learn more

retail therapy · Sep 2023

Entrepreneurship through acquisition.

Bloomberg profiles the world of search funds, where MBA grads look to buy small businesses with money they raise from private investors. ~ learn more

under the microscope · Sep 2023

Platelet factor 4!

“In a remarkable convergence, scientists have discovered that the same blood factor is responsible for the cognitive enhancement that results from young blood transfusion, the longevity hormone klotho, and exercise.” These three “can somehow tell your brain, “Hey, improve your function,” said Saul Villeda, Ph.D., associate director of the UCSF Bakar Aging Research Institute and the senior author on the Nature paper. “With PF4, we’re starting to understand the vocabulary…

under the microscope · Sep 2023

An ‘inverse vaccine’ that can reverse autoimmune diseases.

Outstanding result! “A new type of vaccine developed by researchers at the University of Chicago’s Pritzker School of Molecular Engineering (PME) has shown in the lab setting that it can completely reverse autoimmune diseases like multiple sclerosis and type 1 diabetes — all without shutting down the rest of the immune system.” ~ learn more

under the microscope · Sep 2023

Single-dose psilocybin treatment for major depressive disorder.

A randomized clinical trial of 104 adults, including a placebo group (I wonder if those people quickly figured out which group they were in?). In any case, the results of the psilocybin group look strong. “The primary outcome was change in central rater–assessed Montgomery-Asberg Depression Rating Scale (MADRS) score (range, 0-60; higher scores indicate more severe depression) from baseline to day 43.” The average for the intervention was -12.3, vs…

thoughts of food · Sep 2023

A peek at Cargill’s profits.

“Cargill’s business model has worked for 158 years. Follow the money and you’ll see it ain’t broken yet.” ~ learn more

big ideas · Sep 2023

What the heck happened in 2012?

“The point to all this is just to make explicit what I think so many already know and feel: if we were forced to pinpoint a year, 2012 appears to be a good choice for when the modern world was invented, and we’ve been living in it now for a little over a decade.” ~ learn more

thoughts of food · Sep 2023

The science of great NYC bagels.

This NPR article says it’s not the water, it’s the process. “Traditionally, Coppedge tells The Salt, the chilled dough rings are poached or boiled in a solution of water and malt barley for anywhere from 30 seconds to 3 minutes. This pre-gelatinizes the starch in the dough, locking the liquid inside of it and expanding the interior.” ~ learn more